Imatinib

Imatinib Reactions 1704, p189 - 2 Jun 2018 Erythema multiforme: case report A 70-year-old woman developed erythema multiforme during treatment with imatinib for gastrointestinal stromal tumour (GIST) [route and time to reaction onset not stated]. The woman was diagnosed with GIST and a partial resection of the small intestine including tumour was performed. Subsequently, she started receiving adjuvant chemotherapy with imatinib 400 mg/day. However, she developed grade 4 erythema multiforme during the treatment. The woman’s imatinib treatment was discontinued for 15 days [outcome not stated]. Two years after the tumour resection, recurrence of peritoneal dissemination was observed. Hence, partial tumour resection was observed, and complete resection was performed within next 5 years after the surgery. Author comment: "Imatinib 400mg/day as adjuvant chemotherapy was administered. However administration was stopped for 15 days because of the Grade 4 erythema multiforme." Terada Y, et al. A Case of Small Intestinal GIST with Long-Term Survival after Tumor Resection for Repeated Peritoneal Recurrence. Gan to Kagaku Ryoho 44: 1521-1522, No. 12, Nov 2017 [Japanese; Summarised from an English abstract] - Japan 803322826 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Imatinib

Reactions Weekly , Volume 1704 (1) – Jun 2, 2018
Free
1 page

Loading next page...
1 Page
 
/lp/springer_journal/imatinib-xnTf90enGx
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
D.O.I.
10.1007/s40278-018-46832-5
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p189 - 2 Jun 2018 Erythema multiforme: case report A 70-year-old woman developed erythema multiforme during treatment with imatinib for gastrointestinal stromal tumour (GIST) [route and time to reaction onset not stated]. The woman was diagnosed with GIST and a partial resection of the small intestine including tumour was performed. Subsequently, she started receiving adjuvant chemotherapy with imatinib 400 mg/day. However, she developed grade 4 erythema multiforme during the treatment. The woman’s imatinib treatment was discontinued for 15 days [outcome not stated]. Two years after the tumour resection, recurrence of peritoneal dissemination was observed. Hence, partial tumour resection was observed, and complete resection was performed within next 5 years after the surgery. Author comment: "Imatinib 400mg/day as adjuvant chemotherapy was administered. However administration was stopped for 15 days because of the Grade 4 erythema multiforme." Terada Y, et al. A Case of Small Intestinal GIST with Long-Term Survival after Tumor Resection for Repeated Peritoneal Recurrence. Gan to Kagaku Ryoho 44: 1521-1522, No. 12, Nov 2017 [Japanese; Summarised from an English abstract] - Japan 803322826 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704

Journal

Reactions WeeklySpringer Journals

Published: Jun 2, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off